Rodrigo
Souza
ab,
Natalia
Gérez
a,
Natalia
Besil
c,
María Verónica
Cesio
ad,
Horacio
Heinzen
*ad and
Lucia
Pareja
*c
aGrupo de Análisis de Compuestos Traza, Departamento de Química Orgánica, Facultad de Química, Universidad de la República, General Flores 2124, 11700, Montevideo, Uruguay. E-mail: heinzen@fq.edu.uy
bGraduate Program in Chemistry, Facultad de Química, Universidad de la República, Montevideo, Uruguay
cGrupo de Análisis de Compuestos Traza, Departamento de Química del Litoral, Cenur Litoral Norte, Universidad de la República, Ruta 3 Km 363, 60000, Paysandú, Uruguay. E-mail: lpareja@fq.edu.uy
dGrupo de Análisis de Compuestos Traza, Cenur Litoral Norte, Universidad de la República, Ruta 3 Km 363, 60000, Paysandú, Uruguay
First published on 12th September 2024
The instrumental development of tandem mass spectrometers fosters the actual trend in the trace analysis of organic compounds to the development of methods that allow the analysis of contaminants of the most diverse origin in a single analytical sample. The multiclass methods are aligned with the Who's One Health initiative while accomplishing the concepts of green chemistry. However, there are few reports of wide scope multiclass methods for the analysis of contaminants in this matrix. In this work, a method for the simultaneous determination of 62 compounds in bovine fat, was developed and validated following DG-SANTE/11813/2021 guidance. Liquid nitrogen milled fat was extracted with toluene and acetonitrile. Then a clean-up in a cryogenic bath, followed by dispersive solid phase extraction was performed. Residue determination was done using liquid chromatography for 44 compounds and gas chromatography for 18 compounds, both coupled to tandem mass spectrometry in MRM mode. The method was first developed and validated for two ectoparasiticides, then the scope was expanded for the analysis of 13 veterinary drugs and 49 pesticides. Recovery percentages were in the range of 60–134%, high matrix effect was observed in 50% of the scope of the method. Most compounds presented limits of quantification of 10 μg kg−1 in compliance with international requirements. The method was applied to monitor 49 commercial samples to evaluate its performance. Eighty percent of samples contained ethion and 10% had fluazuron, both within MRLs, highlighting the need for proper withdrawal times.
Distinct regulations govern foods of animal and plant origin, labeled as “pesticides” and “veterinary drugs,” respectively, despite often being the same molecule (codex, EU). Compounds exclusively used in agriculture, lack established MRLs, defaulting to 10 parts per billion (ppb) for enforcement. This unharmonized regulations, has shaped diverse approaches to food safety. Residue analysis for animal-derived foods focuses on specific compound families (antibiotics, antiparasitics, among others), while plant origin analysis relies on multiresidue methods for fungicides, herbicides, and insecticides.
Given the potential for contamination through feed intake and sanitary management, it is essential to consider pesticide exposure in animals within the overall analytical scope of potentially dangerous contaminants in food of animal origin.
The complexity of analyzing contaminants in animal products, particularly in fat matrices, has led to the development of various analytical methods. Fat is a challenging matrix due to its ability to bioaccumulate lipophilic compounds, posing a risk of exposure through food.1 Particularly, organophosphorus and pyrethroids pesticides, antibiotics such as chloramphenicol, parasiticides like ivermectin, with high Kow tend to accumulate in fat tissues and partitionate between the extracting solvent and the fat itself.6
In addition, fat co-extractives are known to pollute the chromatographic system, poisoning electron capture and mass detectors, lowering the overall sensibility of the method; and forcing exhaustive clean-up steps to decrease the levels of co-extractives in the final extract.7,8
Moreover, there are at least two types of fat samples with different water content and lipid composition, the one composed of 100% triglycerides, which is used to fry purposes, and fat tissues, with variable fat content. The U.S. Food and Drug Administration (FDA) defines fatty foods as those with fat content over 2%,9 but Lehotay et al., considered that matrices with a fat content over 20% should be cataloged as high fatty foods.9
Sample treatment can influence the final concentration expressed for each compound. For fatty tissues, old methodologies preferred to melt the sample before extraction, and report the findings on the basis of the melted fat.10 The assumption made is that all the lipophilic compounds are concentrated in fat and their occurrence in other tissues is negligible. This is not the actual trend in the analysis of veterinary drugs and pesticide residues analysis. During the analysis of high fat matrices, it is recommended to express the concentration levels on a lipid adjusted basis, to obtain more representative results in comparison with unadjusted values.10,11 To compare results, the concentration might be expressed as milligrams or micrograms per kilogram of fat.10
Several methods have been developed to address this issue. Akre and Macneil, 2006 utilized Solid Phase Extraction (SPE) and gas chromatography electron capture detection for analyzing synthetic pyrethroids.12 Sartarelli et al., 2014 adapted the QuEChERS method for analyzing pesticides in bovine fat and meat, involving an extraction with acetonitrile and hexane, followed by a clean-up step with PSA and MgSO4, and GC-MS analysis.13 Also, Hmadamin and Hassan developed a variation of the QuEChERS method for the analysis of six pesticides in bovine fat.14 Unterluggauer et al., introduced the FATchers method, a QuEChERS-based approach suitable for fat and tricky matrices, which is widely used in the European Union Reference Laboratory for Food of Animal Origin.15 This method allows the determination of a wide range of compounds with varying polarity, using a combination of liquid–liquid extraction and dispersive solid phase extraction. Other methods, such as those developed by Castillo et al. (2012) and Hoyos et al. (2013), also focus on specific families of contaminants, typically those that are highly lipophilic and GC-amenable.16,17 However, these methods often concentrate on a limited range of compounds, leaving out other relevant contaminants.
A general thought in the past was that this type of methods should be developed only to monitor highly lipophilic compounds, such as organochlorine, organophosphate or pyrethroids insecticides, all GC amenable compounds, leaving out other families of contaminants.9 Nowadays, new lipophilic compounds that are heat sensitive and which also tend to bioaccumulate in fat tissues,18,19 can only be analysed by HPLC (ivermectins, spinosads, spirotetramat and metabolites) and must be determined as well.9
In line with green chemistry concepts, the present work aims to develop and validate a simple and comprehensive multiclass method for the simultaneous analysis of 62 pesticides and veterinary drugs in fat. The proposed method seeks to address the limitations of previous approaches by including a broader range of contaminants, particularly those that are lipophilic, heat-sensitive, and tend to bioaccumulate in fat tissues. By integrating various extraction and clean-up steps, the method offers a more holistic approach to food safety, providing a more representative analysis of potentially hazardous compounds in animal-derived products. This comprehensive approach allows for the simultaneous determination of multiple contaminants at trace levels after a single sample preparation step, enhancing the overall assessment of food safety in the production chain.
For the analysis of pesticides and veterinary drugs the positive MS/MS mode was performed using a mobile phase (MP) of 0.1% formic acid and 5 mM of HCOONH4 in water (A) and 0.1% formic acid and 10 mM of HCOONH4 in MeOH (B). The gradient was 0 min, 98% A, 12 min, 0% A (4 min hold time), and 21 min, 98% A. The re-equilibration time was 5 min.
For negative MS/MS mode, the MP was a mixture of 0.1% of formic acid in water (A) and MeCN (B). The chromatographic method held the initial mobile phase composition 0 min, 50% B; 5 min, 100% B (4 min hold time); 10 min, 50% B. The re-equilibration time until the next injection took 5 min. The flow rate used was 0.6 mL min−1 for positive and negative mode, and the injection volume was 5 μL.
GC amenable analytes were determined using a GC-MS/MS with a Shimadzu GC-2010 plus coupled to MS/MS TQ 8050 spectrometer in Electron Impact ionization (EI) mode. The target analytes were separated in an RTX-5MS (5% diphenyl/95% dimethyl polysiloxane) analytical column (30 m × 0.25 mm i.d. × 0.25 m film thickness), from Restek, (Bellfonte, PA, USA). Tandem mass spectrometry detection was performed in the multiple reaction monitoring (MRM) mode using transitions and collision energies previously selected for each compound using Smart Pesticide Database (SPDB) provided by Shimadzu Corporation.20
The injector temperature was set at 240 °C, interface temperature at 300 °C, and Helium at 14 mL s−1 as carrier gas. Oven temperature: 0 min, 80 °C (2 min hold); 7 min, 180 °C (20 °C min−1 rate); 31 min, 300 °C (5 °C min−1 rate, 3 min hold). The injection volume was 1 μL in splitless mode. The retention times for each pesticide were set using the Automatic Adjustment Retention Time function (AART) ™ (Shimadzu). The AART function stablish the retention times of the target components based on Linear Retention Indices (LRI) and the retention times of n-alkanes. The final MRM method parameters are shown in Table ESI 1.†
Method | Critical step | Variables |
---|---|---|
MSPD | Sample homogenization | With or without N2 |
Dispersant | Alumina or florisil | |
Elution | Type of solvent | |
Volume amount | ||
Concentration factor | ||
QuEChERS | Sample homogenization | With or without N2 |
Sample amount | 2 or 5 g | |
Extraction | Type of solvent | |
Purification | Amount and type of sorbent | |
Ethyl acetate | Sample homogenization | With or without N2 |
Sample amount | 2 or 5 g | |
Extraction | Type of solvent | |
Purification | Amount and type of sorbent |
![]() | ||
Fig. 1 Scheme of the validated methodology for multiclass analysis of veterinary drugs and pesticides in bovine fat. |
Total lipidic content determination was made by gravimetry, as in the method developed by Folch et al.23 This percentage was used in the eqn (1) to express the concentration of each sample in 100% fat.
![]() | (1) |
The evaluation of the selectivity was performed through the injection of blank matrix extractions spiked with a mix of the selected compounds, to check the presence of potential interferences.
Trueness and precision were studied through the determination of recoveries (%Rec) and relative standard deviations (%RSD), at 10, 50 and 100 μg kg−1 by quintuplicate.
Recoveries were calculated based on the comparison between the concentration calculated with the matrix-matched calibration curve and the true concentration for the spiked analytes at each fortification level.
Repeatability and intermediate precision were tested on different days, a %RSD < 20 was considered acceptable.24
The linearity was studied by preparing six-point calibration curves; in pure solvent and in matrix extract, in the range of 5–100 μg kg−1 for HPLC and GC-MS/MS. Coefficient of variations (r2) and Back Calculated Concentration (BCC) residuals of each calibration curve were determined for all the compounds being less than ± 20%.
Matrix effect (ME) was calculated by comparing the slopes of the curves in pure solvent and in the matrix-matched calibration curve. SANTE guidelines suggest that for every compound with a %ME > 20 in absolute value, matrix-matched calibration is mandatory.24 Compounds were classified in three ranges of ME percentages according to Kmellar et al., (2008).25
LOQs were determined as the lowest concentration of each analyte that has been validated with acceptable trueness and precision by applying the complete analytical method for both instruments.24
Compound | Instrumental method | 10 μg kg−1 | 50 μg kg−1 | 100 μg kg−1 | LOQ (μg kg−1) | Matrix effect | MRL (μg kg−1) | |||
---|---|---|---|---|---|---|---|---|---|---|
% rec | % RSD | % rec | % RSD | % rec | % RSD | |||||
Abamectin | HPLC-MS/MS | 88 | 6 | 84 | 10 | 80 | 9 | 10 | 109 | 10 |
Alachlor | HPLC-MS/MS | 81 | 14 | 94 | 2 | 90 | 5 | 10 | 1.3 | 10 |
Ametryn | HPLC-MS/MS | 101 | 4 | 113 | 4 | 106 | 4 | 10 | −8.2 | 10 |
Atrazine | HPLC-MS/MS | 97 | 5 | 116 | 3 | 103 | 3 | 10 | −6.3 | 10 |
Azinphos methyl | GC-MS/MS | 91 | 16 | 104 | 15 | 94 | 18 | 10 | 92 | 10 |
β-Cyfluthrin | GC-MS/MS | nd | nd | 112 | 7 | 101 | 9 | 50 | 71 | 200 |
Byfenthrin | GC-MS/MS | 102 | 54 | 116 | 12 | 96 | 14 | 10 | 49 | 3000 |
Boscalid | HPLC-MS/MS | 143 | 13 | 117 | 5 | 98 | 2 | 10 | 16 | 300 |
Carbofuran | HPLC-MS/MS | 67 | 14 | 115 | 6 | 110 | 10 | 10 | 15 | 10 |
Cypermethrin | GC-MS/MS | 77 | 19 | 90 | 15 | 97 | 11 | 10 | 66 | 2000 |
Clomazone | HPLC-MS/MS | 96 | 4 | 87 | 3 | 84 | 3 | 10 | −1.3 | 10 |
Chlorantraniliprole | HPLC-MS/MS | 104 | 10 | 115 | 5 | 100 | 5 | 10 | 7.1 | 200 |
Chlorfenvinphos | GC-MS/MS | 79 | 11 | 114 | 7 | 106 | 9 | 10 | 54 | 10 |
Chlorpyrifos methyl | GC-MS/MS | 72 | 8 | 105 | 8 | 99 | 12 | 10 | 54 | 10 |
Coumaphos | HPLC-MS/MS | 108 | 4 | 106 | 6 | 97 | 12 | 10 | 74 | 10 |
Diazinon | HPLC-MS/MS | 81 | 6 | 112 | 8 | 96 | 10 | 10 | 38 | 700 |
Difenoconazole | HPLC-MS/MS | 106 | 13 | 133 | 13 | 128 | 19 | 10 | −6.3 | 50 |
Deltamethrin | GC-MS/MS | 70 | 12 | 107 | 10 | 99 | 12 | 10 | 66 | 500 |
Doramectin | HPLC-MS/MS | 88 | 6 | 69 | 10 | 73 | 11 | 10 | 104 | 150 |
Emamectin benzoate | HPLC-MS/MS | 84 | 10 | 80 | 18 | 78 | 9 | 10 | −3.9 | 20 |
Endosulfan sulfate | GC-MS/MS | 120 | 3 | 98 | 15 | 50 | 35 | 50 | ||
Eprinomectin | HPLC-MS/MS | 92 | 13 | 89 | 10 | 76 | 13 | 10 | 107 | 250 |
Ethion | HPLC-MS/MS | 90 | 8 | 101 | 3 | 90 | 7 | 10 | 83 | 10 |
Fenhexamid | HPLC-MS/MS | 63 | 19 | 108 | 16 | 66 | 19 | 10 | −11 | 50 |
Fenthion | HPLC-MS/MS | 70 | 4 | 87 | 18 | 88 | 11 | 10 | 59 | 50 |
Fenvalerate | GC-MS/MS | 70 | 10 | 106 | 10 | 100 | 9 | 10 | 62 | 250 |
Fipronil | GC-MS/MS | 86 | 4 | 134 | 7 | 111 | 11 | 10 | 56 | 30 |
Fluazuron | HPLC-MS/MS | 130 | 12 | 103 | 8 | 96 | 25 | 10 | 66 | 7000 |
Flutriafol | HPLC-MS/MS | 116 | 7 | 127 | 3 | 104 | 1 | 10 | −7.2 | 10 |
Fluvalinate | GC-MS/MS | 70 | 7 | 120 | 15 | 109 | 12 | 10 | 53 | 300 |
Haloxyfop methyl | HPLC-MS/MS | 100 | 5 | 119 | 4 | 97 | 10 | 10 | 7.2 | 10 |
Hexythiazox | HPLC-MS/MS | 96 | 18 | 87 | 7 | 82 | 9 | 10 | 105 | 50 |
Iprodione | GC-MS/MS | 67 | 19 | 105 | 10 | 104 | 11 | 10 | 69 | 10 |
Isoprothiolane | HPLC-MS/MS | 100 | 4 | 116 | 4 | 110 | 4 | 10 | 1.8 | 10 |
Ivermectin | HPLC-MS/MS | 86 | 8 | 73 | 16 | 60 | 8 | 10 | 59 | 100 |
Kresoxim methyl | HPLC-MS/MS | 96 | 7 | 119 | 2 | 111 | 8 | 10 | −1.8 | 50 |
Lambda cyhalothrin | GC-MS/MS | 104 | 19 | 124 | 8 | 112 | 14 | 10 | 49 | 3000 |
Linuron | HPLC-MS/MS | 91 | 4 | 111 | 3 | 108 | 5 | 10 | −12 | 10 |
Malaoxon | HPLC-MS/MS | 111 | 3 | 115 | 3 | 98 | 2 | 10 | −3.5 | 20 |
Malathion | HPLC-MS/MS | 108 | 5 | 111 | 6 | 97 | 2 | 10 | 5 | 20 |
Mebendazole | HPLC-MS/MS | 104 | 4 | 117 | 3 | 106 | 4 | 10 | −2.3 | 60 |
Metconazole | HPLC-MS/MS | 123 | 11 | 81 | 10 | 80 | 6 | 10 | −1.8 | 20 |
Methiocarb | HPLC-MS/MS | 89 | 6 | 104 | 4 | 96 | 5 | 10 | −12 | 30 |
Metolachlor | HPLC-MS/MS | 94 | 5 | 101 | 3 | 98 | 4 | 10 | −4.3 | 10 |
Mirex | GC-MS/MS | 60 | 17 | 81 | 7 | 68 | 11 | 10 | 34 | 10 |
Monensin | HPLC-MS/MS | 83 | 15 | 71 | 10 | 74 | 13 | 10 | 101 | 10 |
Moxidectin | HPLC-MS/MS | 72 | 19 | 60 | 20 | 50 | 21 | 10 | 101 | 500 |
p,p′-DDD | GC-MS/MS | 64 | 24 | 97 | 14 | 110 | 12 | 10 | 90 | 10 |
p,p′-DDT | GC-MS/MS | 67 | 12 | 65 | 12 | 61 | 17 | 10 | 39 | 10 |
p,p′-DDE | GC-MS/MS | 61 | 10 | 79 | 5 | 77 | 8 | 10 | 38 | 10 |
Parathion methyl | GC-MS/MS | 82 | 5 | 117 | 11 | 106 | 10 | 10 | 74 | 10 |
Pendimetalin | HPLC-MS/MS | 91 | 11 | 79 | 5 | 76 | 9 | 10 | 109 | 200 |
Permethrin | GC-MS/MS | 80 | 29 | 114 | 16 | 94 | 13 | 10 | 57 | 500 |
Pyraclostrobin | HPLC-MS/MS | 106 | 9 | 138 | 5 | 102 | 19 | 10 | −12 | 50 |
Pirimifos methyl | HPLC-MS/MS | 76 | 17 | 115 | 10 | 105 | 12 | 10 | 41 | 10 |
Propiconazole | HPLC-MS/MS | 96 | 8 | 92 | 5 | 95 | 8 | 10 | −0.73 | 10 |
Spinosyd A | HPLC-MS/MS | 63 | 27 | 84 | 14 | 73 | 7 | 10 | −24 | 3000 |
Spinosyd D | HPLC-MS/MS | 96 | 23 | 87 | 20 | 104 | 16 | 10 | −35 | 3000 |
Tebuconazole | HPLC-MS/MS | 115 | 12 | 109 | 8 | 114 | 11 | 10 | 0.6 | 100 |
Tebufenozide | HPLC-MS/MS | 116 | 8 | 128 | 3 | 106 | 4 | 10 | −11 | 50 |
Tetraconazole | HPLC-MS/MS | 115 | 18 | 117 | 4 | 104 | 3 | 10 | −12 | 200 |
Triclabendazole | HPLC-MS/MS | 101 | 6 | 97 | 9 | 99 | 3 | 10 | −0.7 | 100 |
Tryfloxystrobin | HPLC-MS/MS | 110 | 6 | 128 | 4 | 105 | 8 | 10 | −11 | 60 |
Triflumuron | HPLC-MS/MS | 133 | 32 | 99 | 12 | 71 | 38 | 10 | −11 | 100 |
Triticonazole | HPLC-MS/MS | 107 | 27 | 100 | 18 | 86 | 10 | 10 | −5 | 10 |
Vinclozolin | GC-MS/MS | 81 | 9 | 129 | 9 | 99 | 10 | 10 | 49 | 10 |
![]() | ||
Fig. 2 HPLC-MS/MS MRM transitions at 100 μg kg−1 of a fat extract and the Extracted Ion Chromatograms (XIC) of (a) fluazuron and (b) ethion at, from left to right, 10, 50 and 100 μg kg−1. |
Based on our previous experience when developing an analytical methodology for beeswax, we decided to make a liquid extraction with MeCN but without melting the fat. The fat was dissolved in toluene and then MeCN was added. A single phase was formed, ensuring that the whole sample was in contact with the extracting solvent. The next step was to eliminate the excess of lipids in the solution. To achieve this goal, the solution was kept for 15 min in a cryocooler at −42 °C. The cooled, solid lipid precipitated and the solution was centrifuged immediately. These steps need to be performed very fast to avoid the melting of the lipids. A refrigerated centrifuge could improve lipid separation. The supernatant was cleaned-up and leaded to the chromatographic-tandem mass spectrometry analysis. It is important to mention that, although good results were obtained, the instruments came dirty very fast. Therefore, a further clean-up was added. After comparing an n-hexane extraction of the MeCN solution and a freeze-out step, the latter proved to be easier and reproducible to perform for routine analysis. So, the solution was kept at −18 °C overnight, filtered and analyzed.
Almost all compounds showed good linearity between 5–100 μg kg−1 for both instruments in pure solvent and matrix-matched, only β-cyfluthrin and endosulfan sulphate had a linear range between 10–100 μg kg−1. Residuals expressed as BCC were below 20% for all the studied compounds.
Although the exhaustive clean-up of the method, matrix effects (ME) were observed for 35 out of the 62 compounds (Fig. 3). Around 37% of the analytes had strong matrix effect (over 50%), whereas 17% showed medium ME, (between 20 and 50%). No relationship between physicochemical properties and the ME profile was found, being organophosphorus pesticides, avermectins and pyrethroids the group with higher ME. As expected, in GC-MS/MS the predominant effect observed was signal enhancement. This may be since certain co-extractives are acting as analyte protectants, preventing compound degradation in the injector or along the chromatographic run.
In HPLC-MS/MS, ME alternated between signal suppression and enhancement depending on each compound. Based on these results, matrix-matched calibration was chosen for the quantification.
All results were corrected according to the lipidic contents of the samples as reported by ref. 13. This correction is important to compare the results with classic methodologies which use melting as sample pre-treatment, to eliminate water and thus, expressing the final concentration as 100% fat, with a deviation between 20–30% compared to the proposed method.13
Footnote |
† Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d4ay00516c |
This journal is © The Royal Society of Chemistry 2024 |